Literature DB >> 20472009

Identification of a novel melittin isoform from Africanized Apis mellifera venom.

Juliana Mozer Sciani1, Rafael Marques-Porto, Airton Lourenço Junior, Ricardo de Oliveira Orsi, Rui Seabra Ferreira Junior, Benedito Barraviera, Daniel Carvalho Pimenta.   

Abstract

Apis mellifera, the European honey bee, is perhaps the most studied insect in the Apidae family. Its venom is comprised basically of melittin, phospholipase A(2), histamine, hyaluronidase, cathecolamines and serotonin. Some of these components have been associated to allergic reactions, among several other symptoms. On the other hand, bee mass-stinging is increasingly becoming a serious public health issue; therefore, the development of efficient serum-therapies has become necessary, with a consequent better characterization of the venom. In this work, we report the isolation and biochemical characterization of melittin-S, an isoform of melittin comprising a Ser residue at the 10th position, from the venom of Africanized A. mellifera. This peptide demonstrated to be less hemolytic than melittin and to adopt a less organized secondary structure, as assessed by circular dichroism spectroscopy. Melittin-S venom contents varied seasonally, and the maximum secretion occurred during the (southern) winter months. Data on the variation of the honey bee venom composition are necessary to guide future immunological studies, aiming for the development of an efficient anti-serum against Africanized A. mellifera venom and, consequently, an effective treatment for the victims of mass-stinging. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20472009     DOI: 10.1016/j.peptides.2010.05.001

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  12 in total

1.  Production of antibacterial peptide from bee venom via a new strategy for heterologous expression.

Authors:  Chunsheng Hou; Liqiong Guo; Junfang Lin; Linfeng You; Wuhua Wu
Journal:  Mol Biol Rep       Date:  2014-09-05       Impact factor: 2.316

Review 2.  Unusual reactions to hymenoptera stings: what should we keep in mind?

Authors:  Ervin Ç Mingomataj; Alketa H Bakiri; Alkerta Ibranji; Gunter J Sturm
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

3.  Massive attack by honeybees in a German shepherd dog: description of a fatal case and review of the literature.

Authors:  Mudassar Niaz Mughal; Ghazanfar Abbas; Muhammad Saqib; Ghulam Muhammad
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2014-12-13

4.  Effect of Bee Venom and Its Fractions on the Release of Pro-Inflammatory Cytokines in PMA-Differentiated U937 Cells Co-Stimulated with LPS.

Authors:  Jonans Tusiimire; Jennifer Wallace; Nicola Woods; Mark J Dufton; John A Parkinson; Grainne Abbott; Carol J Clements; Louise Young; Jin Kyu Park; Jong Woon Jeon; Valerie A Ferro; David G Watson
Journal:  Vaccines (Basel)       Date:  2016-04-19

5.  Melittin induces in vitro death of Leishmania (Leishmania) infantum by triggering the cellular innate immune response.

Authors:  Andreia Vieira Pereira; Gustavo de Barros; Erika Gracielle Pinto; Andre Gustavo Tempone; Ricardo de Oliveira Orsi; Lucilene Delazari Dos Santos; Sueli Calvi; Rui Seabra Ferreira; Daniel Carvalho Pimenta; Benedito Barraviera
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2016-01-08

6.  Apoptotic Effect of Melittin Purified from Iranian Honey Bee Venom on Human Cervical Cancer HeLa Cell Line.

Authors:  Hannaneh Zarrinnahad; Amir Mahmoodzadeh; Monireh Parviz Hamidi; Mehdi Mahdavi; Ali Moradi; Kamran Pooshang Bagheri; Delavar Shahbazzadeh
Journal:  Int J Pept Res Ther       Date:  2017-11-11       Impact factor: 1.931

Review 7.  Bee Updated: Current Knowledge on Bee Venom and Bee Envenoming Therapy.

Authors:  Manuela B Pucca; Felipe A Cerni; Isadora S Oliveira; Timothy P Jenkins; Lídia Argemí; Christoffer V Sørensen; Shirin Ahmadi; José E Barbosa; Andreas H Laustsen
Journal:  Front Immunol       Date:  2019-09-06       Impact factor: 7.561

8.  Single-Arm, Multicenter Phase I/II Clinical Trial for the Treatment of Envenomings by Massive Africanized Honey Bee Stings Using the Unique Apilic Antivenom.

Authors:  Alexandre Naime Barbosa; Rui Seabra Ferreira; Francilene Capel Tavares de Carvalho; Fabiana Schuelter-Trevisol; Mônica Bannwart Mendes; Bruna Cavecci Mendonça; José Nixon Batista; Daisson José Trevisol; Leslie Boyer; Jean-Philippe Chippaux; Natália Bronzatto Medolago; Claudia Vilalva Cassaro; Márcia Tonin Rigotto Carneiro; Ana Paola Piloto de Oliveira; Daniel Carvalho Pimenta; Luís Eduardo Ribeiro da Cunha; Lucilene Delazari Dos Santos; Benedito Barraviera
Journal:  Front Immunol       Date:  2021-03-23       Impact factor: 7.561

Review 9.  Apitoxin and Its Components against Cancer, Neurodegeneration and Rheumatoid Arthritis: Limitations and Possibilities.

Authors:  Andreas Aufschnaiter; Verena Kohler; Shaden Khalifa; Aida Abd El-Wahed; Ming Du; Hesham El-Seedi; Sabrina Büttner
Journal:  Toxins (Basel)       Date:  2020-01-21       Impact factor: 4.546

Review 10.  Neglected Venomous Animals and Toxins: Underrated Biotechnological Tools in Drug Development.

Authors:  Guilherme Rabelo Coelho; Daiane Laise da Silva; Emidio Beraldo-Neto; Hugo Vigerelli; Laudiceia Alves de Oliveira; Juliana Mozer Sciani; Daniel Carvalho Pimenta
Journal:  Toxins (Basel)       Date:  2021-11-29       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.